The MENAT Platelet Rich Plasma (PRP) Tubes market size is projected to grow from US$ 34.08 million in 2021 to US$ 99.28 million by 2028; it is estimated to grow at a CAGR of 16.6% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments. Saudi Arabia is expected to account for the largest share of the market. The market growth is attributed to various factors such as increasing prevalence of orthopedic disorders and sport injuries and growing development in healthcare facilities in the region. Moreover, a surge in cosmetic and aesthetic procedures along with an increase in medspa in the region are likely to accelerate the growth of the MENAT platelet rich plasma tubes market.
Growing Number of Medical Spas to Fuel Platelet Rich Plasma (PRP) Tubes Growth
The Middle East is a leading luxury wellness holiday destination owing to a large presence of medical spas. A wellness program in Oman has incorporated traditional healing practices and pampering treatments that include a hammam and natural hot springs. Also, the growing success of medical spas in the Middle East is attributed to the feature of the facility that combines traditional spa comforts and cosmetic procedures. The UAE is the largest medical spa service provider in the Middle East. Further, Dubai has a high concentration of medical spas per capita across the world. Therefore, the rising number of medical spas offering cosmetic procedures using platelet-rich plasma injections is expected to fuel the MENAT platelet-rich plasma (PRP) tubes market growth in the coming years.
Moreover, incorporation of platelet-rich plasma in regenerative medicine provides opportunity for platelet-rich plasma tubes. Regenerative medicine is a major part of the rapidly emerging biomedical research involving the development of new therapeutic strategies, resulting in significant advancement in the medical field. The rising cases of people suffering from peripheral nerve injury (PNI) have become common across MENAT, and the slow regeneration process of PNI leads to loss of nerve functions. PRP-based treatments have proved to be beneficial in healing acute hamstring-associated injuries, as per the National Institute of Health (NIH) report.
Based on usage, the MENAT platelet rich plasma (PRP) tubes market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynaecology, and others. The orthopedics segment held the largest share of the market in 2021. However, the skin rejuvenation segment is anticipated to register the highest CAGR of 17.3% in the market during the forecast period. The use of platelet-rich plasma (PRP) is expanding to numerous medical fields, including orthopedic surgery and sports medicine. In recent years, platelet rich plasma (PRP) has been widely used to treat orthopedic injuries-related diseases. It is most commonly used to treat orthopedic and sports injuries. PRP therapy is a form of regenerative medicine. Regenerative medicine centers on using the patient’s body tissue such as blood, fat, or bone marrow to heal the body. PRP has been used in operating rooms for several decades to help wound healing and stimulate bone formation in spinal fusion surgery. PRP has recently been used in outpatient settings to treat common overuse conditions, including achilles tendon, rotator cuff tendon, tennis elbow, patellar tendon, plantar fascia, hamstring tendon, and joint pain from arthritis or cartilage wear (particularly the knee).
Based on end user, the MENAT platelet rich plasma (PRP) tubes market is segmented into medspa, dermatology office, hospitals and healthcare practices, tricologist, and others. The hospitals and healthcare practices segment held the largest share of the market in 2021, and it is anticipated to register the highest CAGR of 16.4% in the market during the forecast period. Platelet transfusion was independently associated with ICU-acquired infection. Platelet (PLT) transfusion is used therapeutically in bleeding patients and is also recommended by guidelines to reduce the risk of bleeding in patients with thrombocytopenia (prophylactic transfusion). PRP therapy has been applied to an array of musculoskeletal injuries and has exhibited positive results in most of them.
A few of the major primary and secondary sources referred to while preparing the report on the platelet rich plasma (PRP) tubes market are the Ministry of Investment (Saudi Arabia) and Africa health exhibition.